Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

101.43 -1.10 (-1.07%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

70 71 Next >

Covid Vaccine Rally Dashed As Pfizer, Moderna Give Back Gains On Eris' Advance ↗

August 18, 2023

The companies are hoping to launch their updated Covid shots in September.

Via Investor's Business Daily

Moderna, Pfizer's Updated COVID Shot Shows Effectiveness Against 'Eris' Variant In Early Human, Preclinical Studies ↗

August 18, 2023

Moderna Inc (NASDAQ: MRNA) announced that preliminary clinical trial data confirm its updated COVID-19 vaccine for the fall 2023 vaccination season showed a significant boost in neutralizing antibodies...

Via Benzinga

The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023 ↗

August 17, 2023

This article points you to three undervalued biotech stocks that have the potential to deliver stellar returns for patient investors.

Via InvestorPlace

BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer

August 14, 2023

From BioNTech SE

Via GlobeNewswire

What's Going On With BioNTech (BNTX) Stock? ↗

August 09, 2023

BioNTech SE - ADR (NASDAQ:BNTX) shares are trading higher by 4.66% to $106.51 Wednesday morning as the stock continues to rebound after falling on Monday.

Via Benzinga

What's Happening With BioNTech (BNTX) Stock? ↗

August 08, 2023

BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by 3.28% to $101.73 Tuesday afternoon as the stock rebounds after falling on Monday.

Via Benzinga

BioNTech Se (BNTX) Q2 2023 Earnings Call Transcript ↗

August 07, 2023

BNTX earnings call for the period ending June 30, 2023.

Via The Motley Fool

Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership ↗

August 12, 2023

BeiGene and Bristol-Myers Squibb have formally completed the breakup of the BeiGene-Celgene partnership, returning 23.3 million ordinary BeiGene shares to BeiGene. Meanwhile, Gracell Biotechnologies...

Via Talk Markets

Meet Eris, The COVID Variant Behind A Summer Resurgence In Cases: 3 Drugmakers Prep Fall Booster Shots ↗

August 11, 2023

Via Benzinga

Why BioNTech Stock Was Sinking Today ↗

August 07, 2023

While the waning of the COVID pandemic is a positive development for the world, it's left the German biotech struggling.

Via The Motley Fool

Why Moderna Stock Sunk Today ↗

August 07, 2023

Moderna, Inc. (NASDAQ: MRNA) shares are trading lower on Monday.

Via Benzinga

PayPal Unveils USD-Backed Stablecoin, Trucking Firm Yellow Corp Files For Bankruptcy, FDA Approves First Oral Treatment For Postpartum Depression: Today's Top Stories ↗

August 07, 2023

Benzinga

Via Benzinga

BioNTech Skids As Covid Vaccine-Maker's Sales Plummet And Miss Forecasts ↗

August 07, 2023

The company kept its sales outlook for the year, however.

Via Investor's Business Daily

Preview: BioNTech's Earnings ↗

August 04, 2023

Via Benzinga

Analyst Ratings for BioNTech ↗

August 01, 2023

Via Benzinga

BioNTech Slips Into Quarterly Loss As Q2 Revenue Evaporates, Cuts R&D Spending For FY23 ↗

August 07, 2023

BioNTech SE (NASDAQ: BNTX) has reported Q2 revenues of €167.7 million, sharply down from €3.2 billion a year ago

Via Benzinga

US Stocks Eye Rebound After Big Earnings, But Inflation Data Looms: Analyst Says 3 Factors Can Take S&P 500 Past 4,800 ↗

August 07, 2023

US stocks look set for a cautious start as the week's inflation data will likely keep traders on tenterhooks.

Via Benzinga

BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update

August 07, 2023

From BioNTech SE

Via GlobeNewswire

Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Probably Won't Work. ↗

August 03, 2023

The company hopes to launch an updated Covid booster shot this fall. But there are several complications.

Via Investor's Business Daily

Week In Review: BeiGene Options DualityBio ADC In $1.3 Billion Agreement ↗

July 15, 2023

Deals and financings, trials and approvals in the Chinese biotech/biopharma sphere.

Via Talk Markets

Expert Ratings for BioNTech ↗

July 14, 2023

Via Benzinga

Price Over Earnings Overview: BioNTech ↗

June 29, 2023

Via Benzinga

BioNTech Completes Acquisition of InstaDeep

July 31, 2023

From BioNTech SE

Via GlobeNewswire

Analyst Initiates Arcturus: Sees Attractive Growth Trajectory with Vaccine Franchise Despite Competition ↗

July 24, 2023

William Blair analyst Myles Minter has initiated coverage of Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) with an Outperform rating and a fair

Via Benzinga

BioNTech to Report Second Quarter 2023 Financial Results and Operational Update on August 7, 2023

July 24, 2023

From BioNTech SE

Via GlobeNewswire

Week In Review: Novartis In $1 Billion Deal For DTx Pharma ↗

July 22, 2023

Novartis signed a $1 billion agreement to acquire DTx Pharma, a preclinical San-Diego company developing siRNA therapies for neuroscience indications. Meanwhile, Zhuhai Biotheus formed a far-reaching...

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023 ↗

July 14, 2023

Via Benzinga

3 Biotech Stocks That AI is Loving in July ↗

July 12, 2023

As AI becomes a more entrenched aspect of society, investors can lean on these AI recommended biotech stocks with predicted high potential.

Via InvestorPlace

Why These 7 Stocks Are the Best Ways to Play Biotech Right Now ↗

July 11, 2023

With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look.

Via InvestorPlace

Pfizer, European Pharma Firms Collaborate With European Commission For Future Health Emergency Preparedness ↗

June 30, 2023

The European Commission has reportedly made arrangements with Pfizer Inc (NYSE: PFE) and various European pharmaceutical companies to secure the capacity to produce up to 325 million vaccines annually...

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

70 71 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.